Characterization and biological activity of selenium nanoparticles biosynthesized by Yarrowia lipolytica
Microbial Biotechnology · 2024-10 · 17 (10)
DOI: 10.1111/1751-7915.70013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Biotechnology, online erschienen am 04.10.2024. Verfasst von Elham Lashani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Extremophiles Laboratory, Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran. Hauptthemen laut MEDLINE: Yarrowia, Selenium, Nanoparticles, Anti-Infective Agents. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Discovery grant from Natural sciences and engineering research council of Canada (NSERC), Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
In this research, biogenic selenium nanoparticles were produced by the fungi Yarrowia lipolytica , and the biological activity of its nanoparticles was studied for the first time. The electron microscopy analyses showed the production of nanoparticles were intracellular and the resulting particles were extracted and characterized by XRD, zeta potential, FESEM, EDX, FTIR spectroscopy and DLS. These analyses showed amorphous spherical nanoparticles with an average size of 110 nm and a Zeta potential of −34.51 ± 2.41 mV. Signatures of lipids and proteins were present in the capping layer of biogenic selenium nanoparticles based on FTIR spectra. The antimicrobial properties of test strains showed that Serratia marcescens , Klebsiella pneumonia , Escherichia coli , Pseudomonas aeruginosa and Bacillus subtilis were inhibited at concentrations between 160 and 640 μg/mL, while the growth of Candida albicans was hindered by 80 μg/mL of biogenic selenium nanoparticles. At concentrations between 0.5 and 1.5 mg/mL of biogenic selenium nanoparticles inhibited up to 50% of biofilm formation of Klebsiella pneumonia , Acinetobacter baumannii , Staphylococcus aureus and Pseudomonas aeruginosa . Additionally, the concentration of 20–640 μg/mL of these bioSeNPs showed antioxidant activity. Evaluating the cytotoxicity of these nanoparticles on the HUVEC and HepG2 cell lines did not show any significant toxicity within MIC concentrations of SeNPs. This defines that Y. lipolytica synthesized SeNPs have strong potential to be exploited as antimicrobial agents against pathogens of WHO concern.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Extremophiles Laboratory, Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran.
- Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran.
- Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: Hamid Moghimi, Raymond J Turner
Förderung
- Discovery grant from Natural sciences and engineering research council of Canada (NSERC)
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Lashani, E., Moghimi, H., Turner, R. J., & Amoozegar, M. A. (2024). Characterization and biological activity of selenium nanoparticles biosynthesized by Yarrowia lipolytica. Microbial Biotechnology, 17(10). https://doi.org/10.1111/1751-7915.70013
Vancouver
Lashani E, Moghimi H, Turner RJ, Amoozegar MA. Characterization and biological activity of selenium nanoparticles biosynthesized by Yarrowia lipolytica. Microbial Biotechnology. 2024;17(10). doi:10.1111/1751-7915.70013
BibTeX
@article{Lashani2024,
author = {Lashani, Elham and Moghimi, Hamid and Turner, Raymond J and Amoozegar, Mohammad Ali},
title = {Characterization and biological activity of selenium nanoparticles biosynthesized by Yarrowia lipolytica},
journal = {Microbial Biotechnology},
year = {2024},
volume = {17},
number = {10},
doi = {10.1111/1751-7915.70013}
}
EUVIMED